The primary comparisons evaluated were: DPP-4 inhibitors served as the reference group because, while sharing a common indication (T2DM), they are thought to have lesser neuroprotective effects than the other two classes
It was very obvious from very early on that targeting one pathological process is not going to be enough, Paul Edison, MBBS, PhD, a professor of neuroscience at Imperial College London, told Verywell
Some patients may experience fatigue or dizziness
ColonBroom Ingredients Breakdown: Whats Inside
Kombinr dette med et klart budget, s du ved, hvornr du skal holde pause, og hvornr det giver mening at prve et nyt spil eller en ny taktik